| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.01B | $3.23B | $3.04B |
| YoY Revenue Growth % | -6.7% | +6.3% | — |
| Gross Profit | $1.46B | $1.53B | — |
| Gross Margin % | 48.6% | 47.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $880.0M | $992.0M | $919.0M |
| Operating Margin % | 29.2% | 30.8% | 30.3% |
| Net Income (GAAP) | $623.0M | $731.0M | $673.0M |
| EBITDA (Normalized) | $1.02B | $1.11B | $1.03B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $836.0M | $801.0M | $784.0M |
| Capital Expenditures (CapEx) | $175.0M | $143.0M | $136.6M |
| Free Cash Flow (FCF) | $661.0M | $658.0M | $647.4M |
| FCF Margin % | 22.0% | 20.4% | 21.3% |
| Return on Invested Capital (ROIC %) | 21.3% | 24.0% | 24.1% |
| Cash & Short-Term Equivalents | $1.50B | $781.0M | — |
| Total Debt (Short + Long Term) | $2.88B | $2.40B | $1.17B |
| Total Stockholders' Equity | $1.87B | $1.65B | $2.40B |